Therefore, understanding whether inflammation and metabolic syndrome risk factors contribute to IL-33 production during obesity progression will provide important evidence for further clarification of the interrelationship between obesity, metabolic health and inflammation [7]. This evidence concerns the gene IL33 and metabolic syndrome.